Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.
Royal Dental Group is a Everett, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MicroVision is a Seabrook, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since Bio-Rad was founded over six decades ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 7,800 employees and a global network of operations that serves our life science research and clinical diagnostics customers, helping people live longer, healthier lives.
A&E Medical Corporation is a Farmingdale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.